Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Int J Dermatol. 2013 Jan;52(1):32–40. doi: 10.1111/j.1365-4632.2011.05430.x

Table 2.

Risk of cardiovascular events following psoriasis incidence/index date$

Psoriasis cohort
N events / total		 Non-PSO cohort
N events / total		 Hazards ratio
(95% CI)* 		p-value
Myocardial infarction (by codes only) 124 / 1298 205 / 2602 1.26 (1.01, 1.58) 0.040
Myocardial infarction (validated) 40 / 1328 69 / 2656 1.18 (0.80, 1.74) 0.40
Heart failure 115 / 1314 221 / 2634 1.06 (0.85, 1.33) 0.59
Cardiovascular death 77 / 1344 153 / 2678 1.04 (0.79, 1.37) 0.76
*

adjusted for age, sex and calendar year

$

subjects who experienced selected cardiovascular events prior to incidence/index date excluded